Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells
- PMID: 16081773
- DOI: 10.4049/jimmunol.175.4.2071
Both dendritic cells and macrophages can stimulate naive CD8 T cells in vivo to proliferate, develop effector function, and differentiate into memory cells
Abstract
The generation of T cell immunity requires the acquisition and presentation of Ag on bone marrow-derived APCs. Dendritic cells (DC) are believed to be the most potent bone marrow-derived APCs, and the only ones that can stimulate naive T cells to productively respond to Ags. Because macrophages (Mphi) are bone marrow-derived APCs that are also found in tissues and lymphoid organs, can acquire and present Ag, and can express costimulatory molecules, we have investigated their potential to stimulate primary T cell responses in vivo. We find that both injected Mphi and DCs can migrate from peripheral tissues or blood into lymphoid organs. Moreover, injection of peptide-pulsed Mphi or DCs into mice stimulates CD8 T cells to proliferate, express effector functions including cytokine production and cytolysis, and differentiate into long-lived memory cells. Mphi and DCs stimulate T cells directly without requiring cross-presentation of Ag on host APCs. Therefore, more than one type of bone marrow-derived APC has the potential to prime T cell immunity. In contrast, another bone marrow-derived cell, the T lymphocyte, although capable of presenting Ag and homing to the T cell areas of lymphoid organs, is unable to stimulate primary responses. Because Mphi can be very abundant cells, especially at sites of infection and inflammation, they have the potential to play an important role in immune surveillance and the initiation of T cell immunity.
Similar articles
-
Hematopoietic cells are required to initiate a Chlamydia trachomatis-specific CD8+ T cell response.J Immunol. 2004 Nov 15;173(10):6327-37. doi: 10.4049/jimmunol.173.10.6327. J Immunol. 2004. PMID: 15528372
-
Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.J Immunol. 2005 Jul 15;175(2):855-63. doi: 10.4049/jimmunol.175.2.855. J Immunol. 2005. PMID: 16002683
-
Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.J Immunol. 2002 Jan 15;168(2):661-70. doi: 10.4049/jimmunol.168.2.661. J Immunol. 2002. PMID: 11777959
-
Migration and differentiation of CD8+ T cells.Immunol Rev. 2002 Aug;186:221-33. doi: 10.1034/j.1600-065x.2002.18618.x. Immunol Rev. 2002. PMID: 12234374 Review.
-
Plasticity in programming of effector and memory CD8 T-cell formation.Immunol Rev. 2010 May;235(1):190-205. doi: 10.1111/j.0105-2896.2010.00899.x. Immunol Rev. 2010. PMID: 20536564 Free PMC article. Review.
Cited by
-
Mitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Vaccines (Basel). 2016 Jun 1;4(2):18. doi: 10.3390/vaccines4020018. Vaccines (Basel). 2016. PMID: 27258316 Free PMC article. Review.
-
Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.Hum Vaccin Immunother. 2020 Sep 1;16(9):2183-2195. doi: 10.1080/21645515.2020.1788300. Epub 2020 Aug 5. Hum Vaccin Immunother. 2020. PMID: 32755430 Free PMC article.
-
More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages.Front Immunol. 2019 Aug 27;10:2028. doi: 10.3389/fimmu.2019.02028. eCollection 2019. Front Immunol. 2019. PMID: 31507614 Free PMC article. Review.
-
CCL5 Deficiency Enhanced Cryo-Thermal-Triggered Long-Term Anti-Tumor Immunity in 4T1 Murine Breast Cancer.Biomedicines. 2022 Feb 26;10(3):559. doi: 10.3390/biomedicines10030559. Biomedicines. 2022. PMID: 35327361 Free PMC article.
-
Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response.J Immunother Cancer. 2023 Aug;11(8):e007253. doi: 10.1136/jitc-2023-007253. J Immunother Cancer. 2023. PMID: 37652576 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous